Brian S. Funaki to Liver Neoplasms
This is a "connection" page, showing publications Brian S. Funaki has written about Liver Neoplasms.
Connection Strength
1.579
-
Lack of Technique Standardization Limits Evaluation of Toxicity following Transarterial Chemoembolization. J Vasc Interv Radiol. 2020 08; 31(8):1300-1301.
Score: 0.478
-
Interventional radiologic treatment of hepatocellular carcinoma-a cost analysis from the payer perspective. J Vasc Interv Radiol. 2012 Mar; 23(3):306-14.
Score: 0.265
-
The use of transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: a response to the Cochrane Collaboration review of 2011. J Vasc Interv Radiol. 2011 Dec; 22(12):1693-6.
Score: 0.260
-
Real-time arteriography-directed percutaneous microwave ablation for small or poorly characterized hepatic lesions using hybrid Angio-CT. Abdom Radiol (NY). 2022 04; 47(4):1457-1463.
Score: 0.133
-
Bilioenteric Fistula following Segmental Transarterial Radioembolization. J Vasc Interv Radiol. 2021 12; 32(12):1696-1697.
Score: 0.127
-
Hybrid angiography-CT for transarterial radioembolization: a pictorial essay. Abdom Radiol (NY). 2021 06; 46(6):2850-2854.
Score: 0.123
-
Radiation Dose during Transarterial Radioembolization: A Dosimetric Comparison of Cone-Beam CT and Angio-CT Technologies. J Vasc Interv Radiol. 2021 03; 32(3):429-438.
Score: 0.123
-
ACR Appropriateness Criteria radiologic management of hepatic malignancy. J Am Coll Radiol. 2012 Dec; 9(12):919-25.
Score: 0.070